Inflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes--Biomarkers as a possible tool for early disease detection for rural screening.
暂无分享,去创建一个
H F Jelinek | K Khalaf | H. Jelinek | K. Khalaf | H. Al-Aubaidy | L Maschirow | H A Al-Aubaidy | L. Maschirow | Laura Maschirow
[1] R. Bucala,et al. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. , 2002, Diabetes care.
[2] E. S. Stovgaard,et al. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker in type 2 diabetes. , 2011, Free radical biology & medicine.
[3] Ja Wilson,et al. Principles and practice of screening for disease , 1968 .
[4] R. Schnabel,et al. Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. , 2005, Journal of the American College of Cardiology.
[5] H. Jelinek,et al. D‐dimer identifies stages in the progression of diabetes mellitus from family history of diabetes to cardiovascular complications , 2007, Pathology.
[6] Barbara Thorand,et al. Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[7] E. Sarandöl,et al. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. , 2006, Clinical biochemistry.
[8] O. Ishihara,et al. Isoprostanes, Prostaglandins and Tocopherols in Pre-eclampsia, Normal Pregnancy and Non-pregnancy , 2004, Free radical research.
[9] E. Ferrannini,et al. A comparative study of the in vitro antioxidant activity of statins. , 2003, International journal of cardiology.
[10] John H Fuller,et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.
[11] LloydChambless,et al. Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population , 2006 .
[12] E. Topol,et al. C-reactive protein: a 'golden marker' for inflammation and coronary artery disease. , 2001, Cleveland Clinic journal of medicine.
[13] Xun Jin,et al. Oxidative stress and diabetes mellitus , 2011, Clinical chemistry and laboratory medicine.
[14] S. Penckofer,et al. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. , 2002, The Journal of cardiovascular nursing.
[15] G. Cerniglia,et al. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. , 1990, Analytical biochemistry.
[16] S. Mahajan,et al. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. , 2001, American journal of physiology. Cell physiology.
[17] J. T. Lumeij,et al. Avian Clinical Biochemistry , 1997 .
[18] Wolfgang Rathmann,et al. Prediabetes: a high-risk state for diabetes development , 2012, The Lancet.
[19] Z. Bloomgarden. Consequences of diabetes: cardiovascular disease. , 2004, Diabetes care.
[20] Herbert F Jelinek,et al. 8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort , 2010, Redox report : communications in free radical research.
[21] Guidelines Task Force Clinical. Global guideline for type 2 diabetes , 2012 .
[22] J. Keaney,et al. Role of oxidative modifications in atherosclerosis. , 2004, Physiological reviews.
[23] F. Paccaud,et al. Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about? , 2006, Swiss medical weekly.
[24] I. Graham. Homocysteine as a risk factor for cardiovascular disease. , 1991, Trends in cardiovascular medicine.
[25] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[26] O. Griffith,et al. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. , 1980, Analytical biochemistry.
[27] P. Monk,et al. Complement component 5a (C5a). , 2009, The international journal of biochemistry & cell biology.
[28] M. Yano,et al. Urinary 8‐hydroxy‐2′‐deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure , 2011, European journal of heart failure.
[29] W. T. Cade,et al. Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting , 2008, Physical Therapy.
[30] H. Jelinek,et al. Atherothrombosis and oxidative stress: the connection and correlation in diabetes , 2009, Redox report : communications in free radical research.
[31] J. Shaw,et al. Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) , 2007, Circulation.
[32] H. İlkova,et al. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. , 2002, Metabolism: clinical and experimental.
[33] Edward T H Yeh,et al. Coming of age of C-reactive protein: using inflammation markers in cardiology. , 2003, Circulation.
[34] Ferdinando Giacco,et al. Oxidative stress and diabetic complications. , 2010, Circulation research.
[35] D. Aron,et al. Sexual function in men with diabetes type 2: association with glycemic control. , 2000, The Journal of urology.
[36] R. Tracy. Thrombin, inflammation, and cardiovascular disease: an epidemiologic perspective. , 2003, Chest.
[37] D. Kereiakes,et al. Endothelial dysfunction. , 2003, Circulation.
[38] H. Jelinek,et al. Oxidative DNA damage: antioxidant response in postprandial hyperglycaemia in type 2 diabetes mellitus , 2011 .
[39] Rodica Pop-Busui,et al. Cardiac Autonomic Neuropathy in Diabetes , 2010, Diabetes Care.
[40] Sayeeda Rahman,et al. Diabetes‐associated macrovasculopathy: pathophysiology and pathogenesis , 2007, Diabetes, obesity & metabolism.
[41] G. King,et al. The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society , 2001, Diabetes/metabolism research and reviews.
[42] H. Jelinek,et al. Changes in the erythrocyte glutathione concentration in the course of diabetes mellitus , 2006, Redox report : communications in free radical research.
[43] H. Jelinek,et al. Oxidative DNA damage and obesity in type 2 diabetes mellitus. , 2011, European journal of endocrinology.
[44] I. U. Haq,et al. Statins for primary prevention: at what coronary risk is safety assured? , 2001, British journal of clinical pharmacology.
[45] M. Katz,et al. Reassessing benefits and risks of statins. , 2012, The New England journal of medicine.